PPT-ALLY-2
Design Objective SVR 12 HCV RNA lt 25 IUml with 95 CI in treatmentnaïve genotyp e 1 treated for 12 weeks DCV SOF 400 mg QD DCV SOF 400 mg QD Randomisation 2 1 Openlabel
Download Presentation
"ALLY-2" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.